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Abstract
Postprandial hypoglycemic effect of mulberry leaf (Morus alba L.) was compared in two animal models: Goto-Kakizaki (GK) rats, a spontaneous
non-obese animal model for type II diabetes, and their counterpart control Wistar rats. First, the effect of a single oral administration of mulberry
leaf aqueous extract (MLE) on postprandial glucose responses was determined using maltose or glucose as substrate. With maltose-loading, MLE
reduced peak responses of blood glucose significantly in both GK and Wistar rats (P< 0.05), supporting the inhibition of α-glucosidase by MLE
in the small intestine. With glucose-loading, MLE also significantly reduced blood glucose concentrations, measured at 30 min, in both animal
models (P< 0.01), proposing the inhibition of glucose transport by MLE. Next, dried mulberry leaf powder (MLP) was administered for 8 weeks
by inclusion in the diet. By MLP administration, fasting blood glucose was significantly reduced at weeks 4 and 5 (P < 0.05), but then returned
to values that were similar to those of the control at the end of experimental period in GK rats. Insulin, HOMA-IR, C-reactive protein, and triglycerides
tended to be decreased by MLP treatment in GK rats. All other biochemical parameters were not changed by MLP administration in GK rats. 
Collectively, these findings support that MLE has significant postprandial hypoglycemic effect in both non-obese diabetic and healthy animals, which
may be beneficial as food supplement to manage postprandial blood glucose. Inhibitions of glucose transport as well as α-glucosidase in the small 
intestine were suggested as possible mechanisms related with the postprandial hypoglycemic effect of MLE. 
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Introduction3)
Diabetes mellitus is defined as a condition in which the body 
does not produce enough, or properly respond to, insulin. This 
causes glucose to accumulate in the blood, often leading to 
various complications (Rother, 2007). The total number of people 
with diabetes mellitus worldwide was estimated to rise from 171 
million in 2000 to 366 million by 2030 (Wild et al., 2004). The 
prevalence of diabetes in Asian populations has increased rapidly 
in recent decades. In 2007, more than 110 million individuals 
in Asia were living with diabetes. Unlike in the West, where 
older
  populations are most affected, the burden of diabetes in 
Asian
  countries is disproportionately high in the young and 
middle-aged. Asian diabetes is also characterized by low body 
mass index (Chan et al., 2009).
The major goal in the treatment of diabetes mellitus is keeping 
both short-term and long-term blood glucose levels within 
acceptable limits to reduce the risk of long term complications. 
Although optimizing both fasting blood glucose and postprandial 
glucose levels is important in achieving near-normal glucose 
levels, it has been reported that postprandial glucose levels could 
be a better marker of glycemic control than fasting blood glucose 
levels (Avignon et al., 1997). Some drugs have been developed 
to improve postprandial hyperglycemia by inhibiting intestinal 
α-glucosidase activity. Acabose is a competitive inhibitor of 
sucrase, glucoamylase, and isomaltase. Voglibose has stronger 
α-glucosidase inhibitory activity against maltase and sucrase. 
Miglitol is a strong inhibitor of glucoamylase, sucrase, and 
isomaltase (Goda et al., 2007). However, because the chronic 
use of synthetic α-glucosidase inhibitors can have undesirable 
side effects, such as flatulence, diarrhea, and abdominal 
cramping, their use may be limited. Therefore, attention has 
focused on alternative hypoglycemic agents from natural products 
with effective and safe α-glucosidase inhibition activities and 
fewer side effects (Lee et al., 2007). Mulberry leaves have been 
known as traditional medicine to cure and prevent diabetes 
(Asano et al., 2001).  In particular, 1-deoxynojirimycin (DNJ), 
which is abundant in mulberry leaf (Morus alba L.), is believed 
to be a typical naturally occurring imino sugar with potent 
biological activity (Asano et al., 2001; Kimura et al., 2004). 
*T h i s  p r o j e c t  w a s  s u p p o r t e d  b y  t h e  M i n i s t r y  o f  K n o w l e d g e  &  E c o n o my  (RIS  program,  Project  No.  B0009639  &  RITD  program,  Project  No.  70004683)  and  the 
Ministry  of  Education,  Science  and  Technology  (Brain  Korea  21,  Project  No.  2006-0519-4-7).
§ Corresponding  Author:  Oran  Kwon,  Tel.  82-2-3277-6860,  Fax.  82-2-3277-6860,  Email.  orank@ewha.ac.kr
Received:  October  1,  2009,  Revised:  November  24,  2009,  Accepted:  December  15,  2009
ⓒ2009  The  Korean  Nutrition  Society  and  the  Korean  Society  of  Community  Nutrition
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) 
which  permits  unrestricted  non-commercial  use,  distribution,  and  reproduction  in  any  medium,  provided  the  original  work  is  properly  cited.Ji Min Park et al. 273
Table 1. Dietary fiber and 1-deoxynojirimycin contents (g/100 g)
Components Contents
Mulberry leaf 
aqueous extract
Dietary fiber Soluble 60.97
Insoluble 0.47
Deoxynojirimycin 0.16
Dried mulberry leaf 
powder
Dietary fiber Soluble 30.33
Insoluble 33.86
Deoxynojirimycin 0.05
Table 2. Compositions of experimental diets 
Control
(g/kg diet)
MLP
(g/kg diet)
Ingredients
Cornstarch 397.486 363.726
Dextrinized Cornstarch 132.000 132.000
Sucrose 100.000 100.000
Casein 200.000 182.950
Soybean oil 70.000 65.580
Cellulose 50.000 5.230
Mineral mixture (G) 35.000 35.000
Vitamin mixture 10.000 10.000
L-cystine 3.000 3.000
Choline bitartrate 2.500 2.500
Tert-butylhydroquinone 0.014 0.014
Dried mulberry leaf powder* 0.000 100.000 
Energy (kcal/g) 3.74 3.77
Protein (% kcal/kg) 7.16 7.16
Carbohydrate (% kcal/kg) 23.10 22.36
Fat (% kcal/kg) 6.30 6.30
* Contains  58%  carbohydrate,  4%  fat,  17%  protein,  13%  ash,  and  7%  water.
Many studies have been limited to determine DNJ contents in 
mulberry leaf using ranges of analytical methods and to provide 
a mechanism of DNJ with emphasis on the inhibition of α
-glucosidase. Moreover, there is lack of information on the 
preparations of test materials in many cases. It should be noted 
that wide variations in bioactive constituents can occur in various 
preparations. 
The present study was designed to perform two separate 
experiments to clarify whether mulberry leaf extract (MLE), an 
aqueous extract of dried mulberry leaf powder (MLP) shows 
postprandial hypoglycemic effect via inhibition of α-glucosidase 
activity, to test whether MLE also inhibits glucose transport in 
small intestine and to examine the chronic effect of MLP on 
hyperglycemia and other related metabolic abnormalities. These 
were tested using Goto-Kakizaki  (GK) rats since this animal 
model resembles typical Asian type-2 diabetes, which 
characteristically presents in non-obese individuals, along with 
counterpart Wistar normal rats. 
Materials and Methods
Reagent
Maltose was purchased from Sigma Chemical Co. (St. Louis, 
MO, USA). DNJ and 9-fluorenylmethyl chloroformate were 
purchased from Wako (Osaka, Japan). All other reagents used 
were analytical grade.
Preparations of MLP and MLE 
To prepare the MLP, mulberry leaves (Morus alba L.) were 
procured from a farm in Naju, Korea. Healthy plants were washed 
thoroughly under running tap water, shade dried, and ground to 
a fine powder using an air mill. To prepare the MLE, the MLP 
was infused in hot water at 60℃ for 1 h two times. The whole 
mass was centrifuged, and then the supernatants were freeze- 
dried. The DNJ was analyzed by a reversed-phase high-performance 
liquid chromatography equipped with a fluorescence detector 
after derivatization with 9-fluorenylmethyl chloroformate (FMOC- 
Cl) (Kim et al., 2003). Dietary fibers were also measured using 
the Prosky method (Prosky et al., 1984; Prosky et al., 1992). 
The dietary fiber and DNJ contents in the MLP and MLE are 
shown in Table 1.
Animals
Diabetic GK male rats (SLC, Inc., Hamamatsu, JAPAN) and 
their counterpart control Wistar rats were purchased from Jung-Ang 
Lab Animals Inc. (Seoul, KOREA). The rats were housed in 
individual cages in an air-conditioned room (22-24℃) with a 
12 h light/dark cycle and 45 ± 5% humidity in compliance with 
the Guide for the Care and Use of Laboratory Animals (Nutrition 
Research Council, 1997). Feed (chow or experimental diets) and 
water (boiled and filtered) were provided ad libitum at all times. 
All animals were used in the experiments after 1~4 weeks of 
acclimatization and were killed humanely after the experiments.
Effect of a single dose of MLE using either maltose or glucose 
as substrate 
The GK and Wistar rats (7 weeks old) were divided into 2 
groups (n=5, each) based on body weight and oral glucose 
tolerance tests (OGTT) were performed. The rats were fasted 
overnight for 12 h and then given a single dose of maltose (2 
g/kg body weight) with or without MLE (3.75 g/kg body weight; 
6 mg/kg body weight as DNJ) by gavage feeding. This dose 
was selected taking into account the study that evaluated plasma 
DNJ concentration after oral administration of mulberry DNJ 
(purity > 95%) in the rats (Nakagawa et al., 2007). DNJ level 
in MLE was determined by HPLC before use. Blood glucose 
levels were measured in tail blood samples using an Accu-Check 
(Roche Diagnostics, Manheim, Germany) at 0, 15, 30, 45, 60, 
90, and 120 min after each treatment.
  The incremental area under 
the curve (IAUC) was calculated using the trapezoidal rule with 
fasting levels as the baseline. A week later, the overnight fasted 
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Fig. 1. Effects of MLE on postprandial blood glucose responses in GK rats (A) 
and their counterpart Wistar (B) rats (n=5 each group). The  animals  received 
orally administered maltose (2 g/kg body weight) with or without MLE (3.75 g/kg, 
6  mg/kg  as  DNJ)  after  overnight  fasting  for  12h.  Blood  glucose  levels  were 
determined  from  tail  blood  samples  at  0,  15,  30,  45,  60,  90,  and  120  min  and 
incremental blood glucose concentrations (ΔAUC0-2h) were integrated over a period
of  2  h  (Inset).  Comparisons  were  done  between  MLE  treated  (■)  and  untreated 
control  (□)  rats:  * P < 0.05,  ** P < 0.01.
weight) with or without MLE (same dose as above) by gavage 
feeding, respectively. After 30 minutes, the rats were euthanized 
and blood was collected from the heart for the determination 
of glucose and DNJ. 
Effect of 8-week MLP administration
The GK and Wistar rats (10 weeks old) were stratified 
according to body weight and randomly assigned to control or 
treatment diet (n=10/diet) respectively. The experimental diets 
were formulated based on the nutrient content of the 93G diet 
of the American Institute of Nutrition and MLP inclusion level 
was determined based on the published data (Andallu & 
Varadacharyulu, 2003; Andallu & Varadacharyulu, 2007). The 
MLP diet was adjusted for carbohydrate, protein, and fat to create 
an equivalent energy density as that of the control diet. The 
dietary fiber content of the MLP diet was also adjusted to provide 
the same level as that of the control diet (Table 2). Body weights, 
fasting blood glucose (FBG) levels, and food intake were 
measured every week. After the 8-week period, the rats were 
sacrificed by exsanguinations from the heart under light ether 
anesthesia. The plasma was separated by centrifugation and 
stored at -80℃ until further analysis.
Biochemical assays
Serum glucose was measured using an enzymatic method with 
a test kit from Kodak Ektachem (Rochester, NY, USA). Insulin 
was determined by ELISA with a kit from Mercodia (Uppsala, 
Sweden). Insulin sensitivity was estimated by the homeostasis 
model assessment of insulin resistance (HOMA-IR) [Fasting 
plasma insulin (μU/ml) × fasting blood glucose (mmol/l)/22.5]. 
Hemoglobin A1c (HbA1c) and advanced glycation end products 
(AGEs) were measured using kits from BioSystems (Barcelona, 
Spain) and CycLex Co (Nagano, Japan), respectively. Determ-
inations of triglycerides and free fatty acids were performed by 
enzymatic methods using kits from Asan Pharmaceuticals Ltd. 
(Seoul, Korea) and BioVision (Woburn, MA, USA), respectively. 
C-reactive protein (CRP) was determined by the ELISA method 
using a kit from BioVendor Co. (Modrice, Czech Republic).  
Statistical analysis
All results are expressed as the mean ± standard error. 
Statistical analyses were performed using the SAS program 
package version 9.1. Differences between the control and 
treatment groups were analyzed by Student’s t-test and those at 
P < 0.05 were accepted as significant.
Results
OGTT with MLE, using either maltose or glucose as substrate
Fig. 1 shows that blood glucose concentrations were markedly 
elevated after maltose-loading and reductions in blood glucose 
concentration tended to be delayed in the GK rats compared to 
the normal Wistar rats. Oral administration of MLE significantly 
decreased peak heights of the glucose response at 45 min in the 
GK and at 30 min in Wistar rats by 28% and 62%, respectively, 
compared to the untreated groups (P < 0.05). IAUC, integrated 
over a period of 2 h (ΔAUC0-2h) after maltose-loading, was 
reduced by 11% in the GK rats (not significant statistically), but 
by 49% in the Wistar rats (P < 0.01), as compared to their 
respective controls.
To examine whether MLE also inhibit the glucose uptake in 
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Fig. 2. Effects of MLE on blood glucose increases 30 min after glucose-loading 
in GK rats and their counterpart Wistar rats (n=5 each group). The  animals 
received  orally  administered  glucose  (2  g/kg)  with  or  without  MLE  (3.75  g/kg,  6 
mg/kg as DNJ) after overnight fasting for 12 h. Blood glucose levels were determined 
from tail blood samples at 0 and 30 min and the net increases were calculated. 
Comparisons were done between MLE treated (■) and untreated control (□) rats: 
** P < 0.01.
Fig. 3. Effects of MLP on fasting blood glucose concentrations in GK rats (A) 
and their counterpart Wistar (B) rats (n=10 each group). The animals were fed 
an AIG-93G diet with or without 10% MLP. The diets were adjusted to provide the 
s a m e  c o n t e n t s  o f  d i e t a r y  f i b e r  a n d  c a l o r i e s .  F a s t i n g  b l o o d  g l u c ose  levels  were 
determined from tail blood sample at fixed times. Comparisons were done between
MLP  treated  and  untreated  control  rats:  P < 0.05.
Tmax after a single dose of glucose-loading. The data presented 
in Figure 2 shows that blood glucose increases were significantly 
inhibited by the oral administration of MLE in both the GK and 
Wistar rats (P < 0.01). DNJ was detected in the blood 30 min 
after oral MLE administration in the range of 0~1.14 μmol/L 
(data not shown). 
Eight-week treatment with MLP
There were no differences in body weight or food intake for 
either the GK or Wistar rats by MLP treatment. Based on the 
average food intake data and the specifics of the MLP (Table 
1), DNJ consumption was calculated as 3.15 ± 0.11 mg/kg. 
Physical signs, glutamic oxaloacetic transaminase (GOT), 
glutamic pyruvic transaminase (GPT), total protein, and albumin 
were normal in all groups throughout the treatment period (data 
not shown). 
The FBG levels were determined every week at fixed times 
from the 2
nd week of the experimental period. In response to 
MLP treatment, hyperglycemia was decreased significantly in the 
GK rats at weeks 4 and 5 (P < 0.05), but then glucose returned 
to levels similar to those of the controls towards the end of the 
8-week experimental period. The FBG levels of the Wistar rats 
were not significantly affected in response to MLP treatment 
during the experiment (Fig. 3). 
High FBG, insulin, HOMA-IR, glycated proteins (HbA1c and 
AGEs), and CRP were characteristics of the GK rats. The levels 
of FBG, insulin, HOMA-IR, and CRP were only decreased by 
4%, 12%, 18%, and 25% respectively, with the inclusion of MLP 
in the diet without statistical significances in the GK rats. Wistar 
rats showed no changes in these parameters (Fig. 4, A~C, F). 
Eight week treatment of MLP tended to increase AGEs both in 
the GK and Wistar rats. However, the other glycated protein, 
HbA1c was increased statistically in Wistar rats (Fig. 4, D~E). 
Compared to Wistar rats, the GK rats showed lower blood TG 
and FFA levels. By treating MLP for 8 weeks, TG level was 
decreased by 74% but the difference was not statistically 
significant between two groups in the GK rats (Fig. 4, G~H). 
Discussion
Two separate experiments were performed to investigate the 
antihyperglycemic effects of acute and chronic oral administra-
tion of mulberry leaf (Morus alba L.) in GK rats, the spontaneous 
non-obese animal model for type II diabetes, and their counterpart 
Wistar rats. First, we measured blood glucose levels using a 
single dose of maltose or glucose as substrate to clarify the effects 
of MLE on postprandial blood glucose responses as a result of 
inhibition of α-glucosidase or inhibition of glucose uptake in the 
small intestine. The results clearly show that MLE treatment at 
a dose of 3.75 g/kg body weight (6 mg/kg body weight as DNJ) 
decreased peak glucose responses and the ΔAUC0-2h of post-
prandial blood glucose after maltose-loading in the treated rats 
compared with the non-treated controls. Using wide ranges of 
DNJ concentrations from single pure chemical to mulberry leaf 276 Postprandial hypoglycemic effect of mulberry leaf
(A) (B)
(C) (D)
(E) (F)
(G) (H)
Fig. 4. Effects of 10% MLP in the diet for 8 weeks on biochemical parameters of blood glucose, lipid, and inflammation control in GK rats and their counterpart 
Wistar rats (n=10 each group). A: fasting blood glucose (FBG), B: plasma insulin, C: Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), D: Glycated hemoglobin 
(HbA1C), E: Advanced Glycation End Products (AGEs), F: C-Reactive Protein (CRP), G: Free Fatty Acids (FFAs), H: Triglyceride (TG). Comparisons were done between MLP 
treated  (■)  and  untreated  control  (□)  rats:  P < 0.05. Ji Min Park et al. 277
extracts of different preparations, several studies (Kimura et al., 
2007; Miyahara et al., 2004; Oku et al., 2006; Yatsunami et 
al., 2008) have reported that DNJ, an N-containing sugar 
abundant in mulberry leaf, inhibited the activity of α-glucosidase. 
α-Glucosidase is a key enzyme to metabolize non-absorbable 
oligosaccharides into absorbable monosaccharides in the small 
intestine. Therefore, the glycemic control exerted by MLE might 
have been, at least in part, attributable to α-glucosidase inhibition. 
The results also indicate that postprandial blood glucose 
responses at 30 min after glucose loading were significantly 
decreased by the oral administration of MLE in the GK and 
Wistar rats. Since DNJ is structurally similar to glucose, the 
intestinal absorption of DNJ can be regulated via a glucose 
transporter at the small intestinal brush-border (Voss et al., 2007). 
This beneficial effect shown for glucose absorption is postulated 
to be attributed to the activity of specific constituents in the MLE, 
such as quercetin, which is recognized as an inhibitor of glucose 
absorption (Kwon et al., 2007). In addition, the nutrient 
composition of the MLE (soluble dietary fiber) may have also 
played a role in its effects (Wheeler & Pi-Sunyer, 2008; Wong 
& Jenkins, 2007). 
Next, given the role of MLE in postprandial glucose control, 
we examined the chronic effects of mulberry leaf on hypergly-
cemia and other metabolic abnormalities in GK rats for 8 weeks. 
The MLP was mixed into the diet at 10% (w/w) with adjustments 
of carbohydrate, protein, and fat to provide similar energy density 
and dietary fiber content for all experimental groups. Daily DNJ 
consumption was calculated based on the average food intake 
data and the specifics of MLP and it was about 3 mg/kg body 
weight. MLP administration for 4 and 5 weeks improved FBG 
levels in the GK rats, but these levels returned to values that 
were similar to those of the controls by the end of the 8-week 
treatment. Such discordant results may be partly attributable to 
aging, since it is known that insulin resistance gradually increases 
in GK rats with age. At the end of the experiment, the rats were 
18 weeks old. Therefore, diabetes may have progressed to a more 
severe insulin-resistant stage that could not be mitigated by the 
level of MLP used in this experiment (Igarashi et al., 2007). 
The GK rat is an animal model of spontaneous non-insulin- 
dependent diabetes mellitus. The pathogenesis of diabetes in the 
GK rat includes insulin resistance
  and abnormal glucose 
metabolism (Goto & Efendic, 1993; Janssen et al., 1999) In 
contrast to many other rodent models of type 2 diabetes, GK 
rats do not become obese and do not develop hyperlipidemia 
(Andallu & Varadacharyulu, 2003; Zhou et al., 1995) Accordingly, 
we confirmed that the GK rats showed characteristically higher 
FBG, insulin, HOMA-IR, glycated proteins, CRP and lower TG 
and FFA in the blood compared to those in Wistar rats 
respectively. Eight week treatment of MLP did not show 
statistically significant decreases, but tended to decrease in most 
parameters. Attributing reason of these results seems to be related 
with the lower contents of 1-deoxynojirimycin in MLP and/or 
compensation of dietary fiber of the experimental diet. The 
dietary fiber content of the MLP diet was adjusted to provide 
the same level as that of the control diet. HbA1c was increased 
statistically in Wistar rats. However, it does not provide any 
biological meaning. 
In summary, the present study clearly demonstrates that 
preparations of mulberry leaf with focus on DNJ concentration 
can improve postprandial hyperglycemia and some metabolic 
abnormalities in GK rats. We propose that these effects might 
be mediated through the inhibition of glucose transporter as well 
as inhibition of α-glucosidase at the gut brush-border by specific 
principal phytochemicals and nutrients such as DNJ, quercetin, 
and soluble dietary fiber. Further investigations are in progress 
to elucidate the mechanisms of action of MLE enriched with 
DNJ.
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